Literature DB >> 9270164

Validity of self-reported hysterectomy and tubal sterilisation. The Survey of Women's Health Study Group.

A Green1, D Purdie, L Green, M L Dick, C Bain, V Siskind.   

Abstract

Both hysterectomy and tubal sterilisation offer significant protection from ovarian cancer, and the risk of cardiovascular disease in women is lowered after hysterectomy. Since little is known about the accuracy of women's self-reports of these procedures, we assessed their reliability and validity using data obtained in a case-control study of ovarian cancer. There was 100 per cent repeatability for both positive and negative histories of hysterectomy and tubal sterilisation among a small sample of women on reinterview. Verification of surgery was sought against surgeons' or medical records, or if these were unavailable, from randomly selected current general practitioners for 51 cases and 155 controls reporting a hysterectomy and 73 cases and 137 controls reporting a tubal sterilisation. Validation rate for self-reported hysterectomy against medical reports (32 cases, 96 controls) was 96 per cent (95 per cent confidence interval (CI) 91 to 99) and for tubal sterilisation (32 cases, 77 controls) it was 88 per cent (CI 81 to 93), which is likely to be an underestimate. Although findings are based on small numbers of women for whom medical reports could be ascertained, they are consistent with other findings that suggest women have good recall of past histories of hysterectomy and tubal sterilisation; this allows long-term effects of these procedures to be studied with reasonable accuracy from self-reports.

Entities:  

Mesh:

Year:  1997        PMID: 9270164     DOI: 10.1111/j.1467-842x.1997.tb01710.x

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  11 in total

1.  Deconstructing fatalism: ethnographic perspectives on women's decision making about cancer prevention and treatment.

Authors:  Elaine M Drew; Nancy E Schoenberg
Journal:  Med Anthropol Q       Date:  2011-06

2.  Self-reported pelvic organ prolapse surgery, prevalence, and nonobstetric risk factors: findings from the Nord Trøndelag Health Study.

Authors:  Risa Anna Margaretha Lonnée-Hoffmann; Øyvind Salvesen; Siv Mørkved; Berit Schei
Journal:  Int Urogynecol J       Date:  2014-10-28       Impact factor: 2.894

3.  Breast cancer risk and ovariectomy, hysterectomy, and tubal sterilization in the women's contraceptive and reproductive experiences study.

Authors:  David J Press; Jane Sullivan-Halley; Giske Ursin; Dennis Deapen; Jill A McDonald; Brian L Strom; Sandra A Norman; Michael S Simon; Polly A Marchbanks; Suzanne G Folger; Jonathan M Liff; Ronald T Burkman; Kathleen E Malone; Linda K Weiss; Robert Spirtas; Leslie Bernstein
Journal:  Am J Epidemiol       Date:  2010-11-25       Impact factor: 4.897

4.  Exploring the determinants of racial and ethnic disparities in total knee arthroplasty: health insurance, income, and assets.

Authors:  Amresh D Hanchate; Yuqing Zhang; David T Felson; Arlene S Ash
Journal:  Med Care       Date:  2008-05       Impact factor: 2.983

5.  Hysterectomy and perceived physical function in middle-aged Australian women: a 20-year population-based prospective cohort study.

Authors:  Louise F Wilson; Nirmala Pandeya; Julie Byles; Gita D Mishra
Journal:  Qual Life Res       Date:  2018-02-15       Impact factor: 4.147

6.  Hysterectomy and Bilateral Salpingo-Oophorectomy: Variations by History of Military Service and Birth Cohort.

Authors:  Lisa S Callegari; Kristen E Gray; Laurie C Zephyrin; Laura B Harrington; Megan R Gerber; Barbara B Cochrane; Julie C Weitlauf; Bevanne Bean-Mayberry; Lori A Bastian; Kristin M Mattocks; Sally G Haskell; Jodie G Katon
Journal:  Gerontologist       Date:  2016-02

7.  Association of oral contraceptives and tubal ligation with antimüllerian hormone.

Authors:  Christine R Langton; Brian W Whitcomb; Alexandra C Purdue-Smithe; Lynnette L Sievert; Susan E Hankinson; JoAnn E Manson; Bernard A Rosner; Elizabeth R Bertone-Johnson
Journal:  Menopause       Date:  2021-12-06       Impact factor: 2.953

8.  Hormone replacement therapy and risk of epithelial ovarian cancer.

Authors:  D M Purdie; C J Bain; V Siskind; P Russell; N F Hacker; B G Ward; M A Quinn; A C Green
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

9.  Tubal ligation and risk of breast cancer.

Authors:  L A Brinton; M D Gammon; R J Coates; R N Hoover
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

Review 10.  The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life.

Authors:  Giovanni Grandi; Angela Toss; Laura Cortesi; Laura Botticelli; Annibale Volpe; Angelo Cagnacci
Journal:  Biomed Res Int       Date:  2015-08-30       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.